admin

According to a study from PayScale, cannabis industry employees are more optimistic about the future of their employers than the rest of the U.S. workforce. The study, based on nearly 500 salary profiles from individuals working in both medical and recreational cannabis businesses, found that 68 percent of cannabusiness employees “believe their employers have a […]

by

Waldrop added that the deal allows EVIO to focus on taking market share in California, as demand for testing services throughout the state is “expected to increase significantly.” The companies expect the acquisition to close by the first quarter of 2018 and is subject to customary closing conditions, including due diligence from both C3 Labs and […]

by

The Children’s Hospital of Philadelphia will soon join forces with an Australian pharmaceutical research firm to investigate the effectiveness of medical marijuana treatment in pediatric patients. In a collaborative partnership, CHOP will work with Zelda Therapeutics to conduct an observational study on existing patients with autism, leveraging the hospital’s existing research infrastructure in Philadelphia. RELATED […]

by

THE company planning to build a $100 million medicinal cannabis facility near Casino has announced plans to enter into a major research partnership. PUF Ventures Australia has filed an application with the Australian Office of Drug Control to obtain a medicinal cannabis license and a cannabis research license in collaboration with the National Institute of […]

by

About Matthew Korfhage Matthew Korfhage has lived in St. Louis, Chicago, Munich and Bordeaux, but comes from Portland, where he makes guides to the city and writes about food, booze and books. He likes the Oxford comma but can’t use it in the newspaper. … read more at: http://www.wweek.com/cannabis/2017/12/12/better-blunts-and-cheaper-vapes-three-new-cannabis-products-we-love/

by

Children’s Hospital of Philadelphia is pairing with an Australian biopharmaceutical company in what some advocates say could be the first major effort in the United States to study the effects of medical marijuana on children with autism. Athena Zuppa, the director of the hospital’s Center for Clinical Pharmacology, will lead a team researching current medical marijuana patients. […]

by

Children’s Hospital of Philadelphia is pairing with an Australian biopharmaceutical company in what some advocates say could be the first major effort in the United States to study the effects of medical marijuana on children with autism. Athena Zuppa, the director of the hospital’s Center for Clinical Pharmacology, will lead a team researching current medical marijuana patients. […]

by